The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHemogenyx Share News (HEMO)

Share Price Information for Hemogenyx (HEMO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.53
Bid: 1.53
Ask: 1.60
Change: -0.002 (-0.13%)
Spread: 0.07 (4.575%)
Open: 1.53
High: 1.53
Low: 1.53
Prev. Close: 1.567
HEMO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SMALL-CAP WINNERS & LOSERS: Petrofac gets boost from SocGen upgrade

Mon, 26th Apr 2021 10:50

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday.

----------

SMALL-CAP - WINNERS

----------

Petrofac Ltd, up 4.8% at 121.40 pence, 12-month range 90.66p-241.75p. Societe Generale raises the provider of oilfield services to Buy from Hold.

----------

DWF Group PLC, up 2.6% at 85.8p, 12-month range 45p-90p. The law firm agrees exclusive associations with Singaporean law firm, Eldan Law, and South African law firm, Thomson Wilks. "Like all of our association relationships, this agreement will provide all parties the opportunity to better serve existing and new clients, whilst ensuring consistency, familiarity and quality across the board," says DWF Chief Executive Nigel Knowles.

----------

EnQuest PLC, up 2.5% at 16.38p, 12-month range 8.67p-25.3p. The oil and gas firm buys the Bentley oil discovery in the UK's North Sea from Whalsay Energy Holdings Ltd. EnQuest will pay up to USD2 million in accrued costs for the entire equity interest in the proven Bentley heavy-oil discovery. No other upfront consideration is payable although EnQuest may make deferred payments to Whalsay based on future revenue generated, which are capped at USD40 million.

----------

SMALL-CAP - LOSERS

----------

Hemogenyx Pharmaceuticals PLC, down 15% at 2.70p, 12-month range 1.97p-15.4p. The biotechnology company receives convertible loan note conversion notice from Mint Capital Advisors Ltd. Notice is in respect to GBP900,000 worth of notes issued on February 3. Hemogenyx to issue 29.9 million shares at conversion price of GBP0.03015 each.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
13 Jul 2020 18:25

UK TRADING UPDATE SUMMARY: Mineral & Financial Invests In Ideon Tech

UK TRADING UPDATE SUMMARY: Mineral & Financial Invests In Ideon Tech

Read more
30 Jun 2020 17:07

UK DIRECTOR DEALINGS SUMMARY: TalkTalk Telecom Chair Pays GBP860,000

UK DIRECTOR DEALINGS SUMMARY: TalkTalk Telecom Chair Pays GBP860,000

Read more
26 Jun 2020 14:50

IN BRIEF: Hemogenyx Inks Investigation And Material Supply Deal

IN BRIEF: Hemogenyx Inks Investigation And Material Supply Deal

Read more
15 Jun 2020 17:54

IN BRIEF: Hemogenyx To Take Next Steps In Developing Virus Treatment

IN BRIEF: Hemogenyx To Take Next Steps In Developing Virus Treatment

Read more
2 Jun 2020 12:57

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

Read more
12 May 2020 18:09

Hemogenyx Pharma Placing Raises GBP2.5 Million To Fund Studies

Hemogenyx Pharma Placing Raises GBP2.5 Million To Fund Studies

Read more
1 May 2020 11:18

UK EARNINGS SUMMARY: InfraStrata Targets Breakeven At Titanic Shipyard

UK EARNINGS SUMMARY: InfraStrata Targets Breakeven At Titanic Shipyard

Read more
22 Apr 2020 15:40

UK TRADING UPDATE SUMMARY: BATM Gets EUR29 Million Ventilator Order

UK TRADING UPDATE SUMMARY: BATM Gets EUR29 Million Ventilator Order

Read more
22 Apr 2020 06:55

Hemogenyx Approved For And Issued Hu-PHEC Patent In Europe

Hemogenyx Approved For And Issued Hu-PHEC Patent In Europe

Read more
20 Feb 2020 15:15

Hemogenyx Reports Positive Test Results From Cancer Therapy Treatment

Hemogenyx Reports Positive Test Results From Cancer Therapy Treatment

Read more
11 Feb 2020 12:00

Hemogenyx Gets US Patent For Postnatal Hemogenic Endothelial Cells

Hemogenyx Gets US Patent For Postnatal Hemogenic Endothelial Cells

Read more
30 Jan 2020 15:47

Hemogenyx Raises GBP648,200 To Continue T Cell Therapy Development

Hemogenyx Raises GBP648,200 To Continue T Cell Therapy Development

Read more
15 Jan 2020 13:23

Hemogenyx Shares Jump On Promising Data From Blood Cancer Therapy

Hemogenyx Shares Jump On Promising Data From Blood Cancer Therapy

Read more
18 Nov 2019 11:51

Hemogenyx CDX Antibody Treatment Potentially "Life-Saving"

Hemogenyx CDX Antibody Treatment Potentially "Life-Saving"

Read more
23 Oct 2019 10:43

Hemogenyx signs another deal with unnamed global pharma company

(Sharecast News) - Biopharmaceutical group Hemogenyx Pharmaceuticals announced on Wednesday that its wholly-owned subsidiary Immugenyx has entered into a research agreement with a global pharmaceutical company.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.